Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Endo Health Solutions Inc Reaffirms FY 2013 Guidance


Tuesday, 7 May 2013 07:01am EDT 

Endo Health Solutions Inc announced that for fiscal 2013, it expects revenues in the range of $2.80-$2.95 billion, diluted (GAAP) EPS in the range of $2.10 to $2.40 and adjusted diluted EPS in the range of $4.40 to $4.70. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $2.90 billion and EPS of $4.49 for fiscal 2013. 

Company Quote

63.28
-0.53 -0.83%
4:00pm EDT